In a significant advancement for diabetes care, Tan Tock Seng Hospital (TTSH) in Singapore has collaborated with health-tech company BUZUD to unveil CARB-CGM, an AI-powered mobile application paired with a continuous glucose monitoring (CGM) device. This innovative system is designed to simplify the complexities of diabetes management, offering patients real-time glucose readings and AI-driven dietary analysis to empower them in making informed health decisions.
Streamlining Diabetes Management with CARB-CGM
Managing diabetes often involves meticulous monitoring of blood glucose levels and careful dietary planning. The CARB-CGM system integrates advanced AI technology with continuous glucose monitoring to address these challenges. Patients can now receive minute-by-minute glucose readings through a wearable sensor, enabling continuous tracking of their glucose levels.
A standout feature of the CARB-CGM system is its AI-powered dietary analysis. By capturing a photo of their meal, patients can use the app to identify the food and estimate its carbohydrate content. This functionality allows for more accurate insulin dosing, reducing the risks associated with hyperglycemia and hypoglycemia.
See how TrueNAS offers real-time support for healthcare data managers.
Additionally, the system calculates personalized insulin sensitivity factors based on individual health data, ensuring that insulin dosage recommendations are tailored to each patient’s unique needs. This personalized approach aims to enhance glycemic control and improve overall health outcomes.
Empowering Patients and Enhancing Care
The introduction of CARB-CGM addresses the daily challenges faced by patients requiring multiple insulin doses. Insulin dosage decisions depend on various factors, including health condition, lifestyle, daily routines, and food intake, which can vary significantly. Miscalculations in insulin dosing can lead to serious complications, such as hyperglycemia or hypoglycemia, hindering patients’ progress and confidence.
Adjunct Associate Professor Daniel Chew, Division Chairman (Medicine) at TTSH, emphasized the importance of empowering patients and caregivers to navigate these complexities. He stated, “For some patients, managing diabetes means making numerous micro-decisions every day. It is critical that we empower our patients and their caregivers to navigate complexities and be confident in their care regimes. An enhanced CARB-CGM solution can take out the guesswork on insulin administration.”
This collaboration marks a pivotal moment in patient care, delivering enhanced outcomes through better glycemic control and personalized support. Data-driven insights enable healthcare teams to optimize treatment decisions and improve long-term care management. By reimagining diabetes management through AI technology, the partnership focuses on reducing complications and improving the quality of life for patients.
Leveraging Expertise to Accelerate AI Adoption
The partnership between TTSH and BUZUD, facilitated by the National Healthcare Group’s (NHG) Centre for Medical Technologies and Innovations (CMTi), highlights the importance of collaboration between public and private sectors to address unmet healthcare needs. Digital technologies have made significant strides in diagnostics and treatment, and this partnership leverages TTSH’s strong culture of innovation to showcase the transformative potential of AI technologies in enhancing patient care and empowerment.
The collaboration was formalized with the signing of a Research Collaboration Agreement between Mr. Christopher Soh, Deputy Director of Nursing at TTSH, and Mr. Frankie Fan, CEO of BUZUD. This agreement underscores the commitment of both organizations to advancing healthcare through technological innovation.
Following the introduction of the CARB-CGM system, the next phase of the partnership involves a validation study to assess its accuracy and effectiveness. This will be followed by a pilot adoption phase with a small group of patients before expanding to include more patients in subsequent stages. The iterative approach ensures that the system meets the diverse needs of the patient population and continues to evolve based on real-world feedback.
References
- BUZUD and Tan Tock Seng Hospital Unveil AI-Powered Diabetes Management Solution – BUZUD Singapore
- Reimagining The Future of Diabetes Care Through Collaboration and Technology – Tan Tock Seng Hospital, Singapore
- TTSH helps refine AI-enabled tool that will calculate accurate insulin dosage for diabetics – The Straits Times
- New Artificial Intelligence Tool Invented by Tan Tock Seng Hospital and ASUS to Speed up Diagnosis of Blood Abnormalities – Tan Tock Seng Hospital
- Smart wards: Singapore hospitals use technology to cope with manpower needs – The Straits Times
- New diabetes app emphasises foot care, foot ulcer awareness – MobiHealthNews
- Yonsei University opens medical robot training centre and more briefs – Healthcare IT News
- S$35M research funding to leverage AI to reduce risk of diabetes, high cholesterol and high blood pressure in Singapore – AI Singapore
- ASUS and Tan Tock Seng Hospital co-develop an AI-based tool to improve the accuracy and efficiency of diagnosis in blood diseases – PR Newswire APAC
- Smart wards: Singapore hospitals use technology to cope with manpower needs – Tan Tock Seng Hospital
Be the first to comment